Prestige Consumer Healthcare Net Income 2010-2025 | PBH
Prestige Consumer Healthcare net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Prestige Consumer Healthcare Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $215 |
| 2024 | $209 |
| 2023 | $-82 |
| 2022 | $205 |
| 2021 | $165 |
| 2020 | $142 |
| 2019 | $-36 |
| 2018 | $340 |
| 2017 | $69 |
| 2016 | $100 |
| 2015 | $78 |
| 2014 | $73 |
| 2013 | $66 |
| 2012 | $37 |
| 2011 | $29 |
| 2010 | $32 |
| 2009 | $-187 |
| Prestige Consumer Healthcare Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $50 |
| 2024-12-31 | $61 |
| 2024-09-30 | $54 |
| 2024-06-30 | $49 |
| 2024-03-31 | $49 |
| 2023-12-31 | $53 |
| 2023-09-30 | $54 |
| 2023-06-30 | $53 |
| 2023-03-31 | $-241 |
| 2022-12-31 | $52 |
| 2022-09-30 | $51 |
| 2022-06-30 | $55 |
| 2022-03-31 | $52 |
| 2021-12-31 | $50 |
| 2021-09-30 | $45 |
| 2021-06-30 | $58 |
| 2021-03-31 | $36 |
| 2020-12-31 | $41 |
| 2020-09-30 | $45 |
| 2020-06-30 | $44 |
| 2020-03-31 | $37 |
| 2019-12-31 | $38 |
| 2019-09-30 | $33 |
| 2019-06-30 | $34 |
| 2019-03-31 | $-139 |
| 2018-12-31 | $38 |
| 2018-09-30 | $31 |
| 2018-06-30 | $34 |
| 2018-03-31 | $-40 |
| 2017-12-31 | $315 |
| 2017-09-30 | $31 |
| 2017-06-30 | $34 |
| 2017-03-31 | $11 |
| 2016-12-31 | $32 |
| 2016-09-30 | $32 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $14 |
| 2015-12-31 | $28 |
| 2015-09-30 | $32 |
| 2015-06-30 | $26 |
| 2015-03-31 | $24 |
| 2014-12-31 | $21 |
| 2014-09-30 | $16 |
| 2014-06-30 | $17 |
| 2014-03-31 | $16 |
| 2013-12-31 | $3 |
| 2013-09-30 | $33 |
| 2013-06-30 | $21 |
| 2013-03-31 | $19 |
| 2012-12-31 | $12 |
| 2012-09-30 | $19 |
| 2012-06-30 | $15 |
| 2012-03-31 | $0 |
| 2011-12-31 | $10 |
| 2011-09-30 | $13 |
| 2011-06-30 | $15 |
| 2011-03-31 | $6 |
| 2010-12-31 | $2 |
| 2010-09-30 | $11 |
| 2010-06-30 | $10 |
| 2010-03-31 | $3 |
| 2009-12-31 | $11 |
| 2009-09-30 | $10 |
| 2009-06-30 | $8 |
| 2009-03-31 | $-211 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.770B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.828B | 25.79 |
| Boston Scientific (BSX) | United States | $156.585B | 37.40 |
| Stryker (SYK) | United States | $152.939B | 31.98 |
| EssilorLuxottica (ESLOY) | France | $137.925B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.343B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.576B | 24.87 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.596B | 16.90 |
| Agilent Technologies (A) | United States | $33.957B | 22.14 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $24.709B | 17.34 |
| Insulet (PODD) | United States | $20.568B | 80.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.989B | 12.20 |
| Baxter (BAX) | United States | $14.636B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.656B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.891B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $5.010B | 12.64 |
| Perrigo (PRGO) | Ireland | $3.867B | 9.80 |
| Haemonetics (HAE) | United States | $3.587B | 16.34 |
| Envista Holdings (NVST) | United States | $3.515B | 29.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.138B | 23.14 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| QuidelOrtho (QDEL) | United States | $1.764B | 12.14 |
| AtriCure (ATRC) | United States | $1.645B | 0.00 |
| Acuren (TIC) | United States | $1.367B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.96 |
| AdaptHealth (AHCO) | United States | $1.294B | 13.14 |
| Neogen (NEOG) | United States | $1.176B | 15.06 |
| Phibro Animal Health (PAHC) | United States | $1.172B | 14.98 |
| BioLife Solutions (BLFS) | United States | $1.063B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.987B | 0.00 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| Valneva SE (VALN) | France | $0.648B | 0.00 |
| Owens & Minor (OMI) | United States | $0.608B | 5.04 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| CeriBell (CBLL) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.524B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.82 |
| SNDL (SNDL) | Canada | $0.394B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.358B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.97 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.310B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.306B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 79.67 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.246B | 20.77 |
| Biote (BTMD) | United States | $0.239B | 6.72 |
| Verano Holdings (VRNOF) | United States | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.227B | 60.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.45 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.83 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Apyx Medical (APYX) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.38 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |